These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33199324)

  • 1. Raynaud's phenomenon.
    Haque A; Hughes M
    Clin Med (Lond); 2020 Nov; 20(6):580-587. PubMed ID: 33199324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon.
    Devgire V; Hughes M
    Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical management of Raynaud's phenomenon - a primer for practicing physicians.
    Ramahi A; Hughes M; Khanna D
    Curr Opin Rheumatol; 2022 Jul; 34(4):235-244. PubMed ID: 35699336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon-an update on diagnosis, classification and management.
    Pauling JD; Hughes M; Pope JE
    Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Næser EU; Søndergaard K
    Ugeskr Laeger; 2022 Oct; 184(43):. PubMed ID: 36331170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Points to consider-Raynaud's phenomenon in systemic sclerosis.
    Cutolo M; Smith V; Furst DE; Khanna D; Herrick AL
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v45-v48. PubMed ID: 28992170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Nailfold Capillaroscopy in the Classification and Differential Diagnosis of Raynaud's Phenomenon in Rheumatology.
    Lambova SN
    Curr Rheumatol Rev; 2024; 20(2):108-114. PubMed ID: 37691224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomenon].
    Zeni S; Ingegnoli F
    Reumatismo; 2004; 56(2):77-81. PubMed ID: 15309214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of internet-based information for individuals with Raynaud's phenomenon and patients with systemic sclerosis.
    Devgire V; Martin AF; McKenzie L; Sandler RD; Hughes M
    Clin Rheumatol; 2020 Aug; 39(8):2363-2367. PubMed ID: 32152916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Raynaud's phenomenon and sclerodermia].
    Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
    Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
    [No Abstract]   [Full Text] [Related]  

  • 16. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.
    Pauling JD; Reilly E; Smith T; Frech TM
    Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1119-1126. PubMed ID: 30133174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raising awareness of Raynaud's phenomenon and scleroderma.
    Mawdsley AH; Brown SJ
    Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.